Despite recent progress in mapping transcriptional regulatory elements and chromatin states [1] [2] [3] [4] [5] [6] [7] , there is still limited understanding of how transcription factor networks interact with chromatin to control genome function. Furthermore, little is known about how the dysregulation of such networks contributes to disease. As pancreatic islet cells are pivotal in diabetes pathogenesis [8] [9] [10] and genomic cisregulatory maps in islets are still markedly underdeveloped compared to those for other cell types 5, 7, [11] [12] [13] [14] [15] [16] , we have now mapped chromatin states, binding sites of key transcription factors and transcripts in human pancreatic islets (Fig. 1a) . Integrative analysis and genetic perturbations were combined to provide reference charts of the cis-regulatory elements functioning in human pancreatic islets. Our studies identified enhancer domains that are central determinants of islet-specific gene activity and linked sequence variation in these regions to susceptibility for type 2 diabetes (T2D) and to variation in fasting glycemia levels.
Despite recent progress in mapping transcriptional regulatory elements and chromatin states [1] [2] [3] [4] [5] [6] [7] , there is still limited understanding of how transcription factor networks interact with chromatin to control genome function. Furthermore, little is known about how the dysregulation of such networks contributes to disease. As pancreatic islet cells are pivotal in diabetes pathogenesis [8] [9] [10] and genomic cisregulatory maps in islets are still markedly underdeveloped compared to those for other cell types 5, 7, [11] [12] [13] [14] [15] [16] , we have now mapped chromatin states, binding sites of key transcription factors and transcripts in human pancreatic islets (Fig. 1a) . Integrative analysis and genetic perturbations were combined to provide reference charts of the cis-regulatory elements functioning in human pancreatic islets. Our studies identified enhancer domains that are central determinants of islet-specific gene activity and linked sequence variation in these regions to susceptibility for type 2 diabetes (T2D) and to variation in fasting glycemia levels.
RESULTS

Topology of an essential islet transcription factor network
To characterize the transcription factor networks that control gene activity in human islet cells, we focused on five key β cell transcription factors-FOXA2, MAFB and NKX2.2, which are expressed in insulin-producing β cells and other major islet cell types; NKX6.1, which is specific to β cells; and PDX1, which is present in β cells and more scarce somatostatin-producing islet cells [17] [18] [19] [20] [21] ( Supplementary  Fig. 1a -c and Supplementary Table 1 ). Mouse genetic experiments have shown that these five transcription factors are essential for the differentiation or function of β cells [22] [23] [24] , yet little is known about how these factors function at the level of regulatory networks or how they interact with human islet chromatin to create cell type-specific transcriptional activity. To determine the genomic binding sites of these islet transcription factors, we used chromatin immunoprecipitation and sequencing (ChIP-seq) in duplicate human islet samples and identified 3,911-32,747 high-confidence sites per transcription factor ( Supplementary  Figs. 1d,e and 2a,b) . We found that all five transcription factors invariably bound to multiple sites in the vicinity of their own and each other's genes, a pattern indicating autoand cross-regulatory interactions (Fig. 1b,c and Supplementary Fig. 2c-f) . Furthermore, all five transcription factors frequently bound to overlapping genomic sites, and, consequently, their genomic binding signals were highly correlated (r = 0.36-0.68 between pairs of islet transcription factors in contrast with r = 0.03-0.11 between islet transcription factors and a control non-islet transcription factor) (Fig. 1b,c and Supplementary  Fig. 2c-h ). This systematic analysis shows that, in agreement with earlier descriptions of transcription factor networks in diverse species and tissues 25, 26 , human islet-specific transcription factors form a remarkably interconnected network (Fig. 1c) . These genome-scale maps of binding sites for key islet transcription factors provide a framework for understanding how transcription factors control isletspecific gene transcription.
Islet transcription factors bind to distinct chromatin states
We next sought to understand the relationship between the binding sites of islet-specific transcription factors and underlying chromatin states in human islets. We first mapped all accessible, or open, chromatin sites in pancreatic islets. We combined two assays that capture overlapping, although not identical, sets of accessible chromatin sites: FAIRE-seq, which uses formaldehyde-assisted isolation of regulatory elements to identify open (nucleosome-depleted) sites 5 , and ChIP-seq for H2A.Z, a histone variant that is enriched in accessible chromatin sites 27, 28 . We defined ~95,000 sites that were enriched in either of these 2 accessible chromatin types in 2 or more human islet samples. Next, we mapped key histone modifications (monomethylation of histone H3 at lysine 4 (H3K4me1), trimethylation of histone H3 at lysine 4 (H3K4me3) and acetylation of histone H3 at lysine 27 (H3K27ac)) and CTCF-binding sites in human islets and used k-median clustering to divide all accessible chromatin sites into five classes (C1-C5) that displayed clearly recognizable enrichment patterns for histone modifications and CTCF binding [1] [2] [3] , namely, promoters (C1), poised or inactive enhancers (C2), active enhancers (C3), CTCF-bound sites (C4) and additional accessible sites lacking active histone modifications and CTCF occupancy (C5) (Fig. 2a and Supplementary Fig. 3a-c) . Consistent with our expectation that transcription factors would bind to accessible DNA, 92% of the genomic sites bound by any of the five islet-specific transcription factors mapped to sites that showed enrichment in FAIRE-seq or H2A.Z ChIP-seq in at least one sample, and islet transcription factors bound to all major classes of accessible chromatin ( Fig. 2b and Supplementary Fig. 4 ). Integrating histone marks and transcription factor binding maps thus resolved discrete classes of transcription factor-bound accessible chromatin sites in human islets.
Cis-regulatory clusters drive islet-specific transcription
Next, we examined the functional relationship between these different classes of transcription factor-bound, accessible chromatin sites and islet-specific gene transcription. To study islet-specific gene transcription, we analyzed RNA sequencing (RNA-seq) profiles from 3 human islet samples 29 , 2 fluorescence-activated cell sorting (FACS)-purified β cell samples 29 and 14 non-pancreatic tissues and used these profiles to define 3 classes of genes: (i) islet-specific genes, which included the 1,000 genes that showed the strongest transcript enrichment in human islet cells, (ii) ubiquitously transcribed genes, which included 1,000 genes that were similarly active in islet cells and other tissues, and (iii) inactive genes, which included the 1,000 genes that showed the lowest expression levels in islet cells. Contrary to our expectation that cell type-specific transcription factors should primarily bind to cell type-specific genes, islet-specific transcription factors bound to promoter (C1) accessible chromatin to a similar extent at both islet-specific and ubiquitously transcribed genes (Fig. 2c,d and Supplementary Fig. 5a,b) . Similarly, binding events of islet-specific transcription factors at C2, C4 and C5 accessible chromatin sites were not enriched at loci harboring genes specifically expressed in islet cells ( Fig. 2c and Supplementary Fig. 5c ). In sharp contrast, gene loci with islet-specific expression had a higher density of islet transcription factor-bound active enhancer (C3) accessible chromatin sites (Fig. 2c,e) . These genes with islet-specific expression had a median of 3 transcription factor-bound C3 sites (interquartile range (IQR) = 1-5) within 50 kb of their transcriptional start site (TSS), whereas ubiquitously transcribed genes had 1 (IQR = 0-3) and islet-inactive genes had a median of 0 (IQR = 0-1) transcription factor-bound C3 sites (Kruskall-Wallis P < 1 × 10 −16 ). Consistent with studies showing that combinatorial transcription factor interactions are critical for enhancer activation 30, 31 , 72.8% of genomic sites bound by three or more islet-specific transcription factors were associated with C3 accessible chromatin (Fig. 2f) . Although some promoter (C1) accessible chromatin sites were also bound by multiple islet transcription factors, these sites were not associated with isletspecific transcription, suggesting that the link between transcription A r t i c l e s factor occupancy and cell type-specific transcription is largely confined to active enhancers ( Fig. 2g and Supplementary Fig. 5d ). Taken together, these findings showed remarkable differences between transcription factor binding at sites in the different accessible chromatin classes. These findings suggest that certain binding events of islet-specific transcription factors, such as those occurring at promoters, are not generally associated with cell type-specific gene transcription, which is instead tightly linked to clusters of active enhancer sites bound by multiple transcription factors. We scanned the genome to identify all clusters of three or more enhancer sites active in islets (Online Methods and Supplementary  Fig. 6a,b) . We identified 3,677 such clusters, which mapped near genes with strong islet-enriched expression (median expression in islets of 8.3 reads per kilobase per million mapped reads (RPKM) (IQR = 2.9-19.6) and in non-islet tissues of 4.8 RPKM (IQR = 0.7-14.2); Wilcoxon P < 1 × 10 −30 ), in contrast to more modest islet enrichment in genes near non-clustered (orphan) enhancers (median expression in islets of 6.0 RPKM (IQR = 1.5-14.3) and in non-islet tissues of 5.0 RPKM (IQR = 0.8-13.9); Wilcoxon P < 1 × 10 −5 ) (Supplementary Fig. 6c ). Islet-enriched transcription was most pronounced near the 1,813 enhancer clusters that showed higher than median occupancy by islet transcription factors ( Fig. 2h and Supplementary Fig. 7a-c) . Remarkably, most genes that are currently known to be important for islet cell identity, function or disease were associated with an islet enhancer cluster (92% of a manually annotated list of 65 such genes, 90% of which belonged to the subset with high transcription factor occupancy; Supplementary Fig. 7d and Supplementary Table 2 ). These findings reinforce the view that the genomic program that underlies islet cell identity is tightly associated with clusters of enhancers bound by islet transcription factors.
To investigate the function of transcription factor-bound enhancer clusters, we first verified that individual clustered C3 sites truly acted as cell type-specific enhancers. Consistent with their chromatin signature, 8 of 12 transcription factor-bound active enhancer C3 sites (but not transcription factor-bound C2 or C5 sites) displayed β cellselective enhancer activity in episomal reporter assays in mouse cell lines (Fig. 3a) . Five conserved transcription factor-bound C3 sites were tested in transgenic zebrafish assays, and all exhibited Fig. 3a) . Histoneand CTCF-bound reads were divided into 100-bp bins across 6-kb windows centered on merged FAIRE-or H2A.Z-enriched sites. (b) Average transcription factor binding signal distribution relative to the center of each accessible chromatin class and the percentage of sites in each class bound by at least one transcription factor. Non-quantile-normalized reads were processed as described for a. (c) Density of C1, C2 and C3 accessible chromatin sites bound by 2 or more transcription factors in the regions surrounding the TSSs of the 1,000 genes with the most islet-specific expression, 1,000 ubiquitously active genes and 1,000 isletinactive genes. (d,e) Examples of islet-specific transcription factor binding to the 5′ ends of the ubiquitously active genes TBP and PSMB1 (d) or to the islet-specific T2D susceptibility gene SLC30A8 (e). The regulome track depicts colored chromatin states for classes C1-C5. npg enhancer activity (three specifically in the pancreatic islet), whereas transcription factor-bound C2 and C5 sites showed no activity ( Fig. 3b and Supplementary Fig. 8a-c) . These experiments show that clustered sites have islet enhancer activity.
We next designed experiments to directly test whether transcription factor binding sites that were present in clusters of enhancers, but not necessarily other transcription factor binding sites, were functionally important for the activation of islet-selective genes. First, we transduced human β cells (EndoC-β H1) with two independent interfering hairpin RNAs for MAFB or with four control hairpins ( Supplementary Fig. 9a ). Knockdown of MAFB caused downregulation of genes linked to MAFB-bound enhancer clusters (Gene Set Enrichment Analysis (GSEA) normalized enrichment score (NES) = 1.98, false discovery rate (FDR) q < 1.5 × 10 −2 ) (Fig. 3c) , such as ROBO2 and G6PC2 (Supplementary Fig. 9b,c) .
However, the expression of genes bound by MAFB only at their promoters or at other classes of accessible chromatin was not significantly affected ( Fig. 3c and Supplementary Fig. 9d,e) . Next, we transfected HEK293T embryonic kidney cells with expression vectors encoding PDX1 and assessed which PDX1-bound genes were activated. We coexpressed PDX1 with MAFA and NGN3 because this transcription factor combination, which has previously been employed to activate β cell genes 32 , was more efficient than PDX1 alone in gene activation in heterologous cells. We observed transcriptional enhancement of genes near PDX1-bound enhancer clusters (GSEA NES = 2.2, FDR q < 1 × 10 −3 ), whereas the expression of genes that were exclusively bound by PDX1 at promoter or other accessible chromatin classes was unaffected (GSEA NES = −1.3, FDR q = 0.37) (Fig. 3d) . These studies confirm that chromatin profiling can identify subsets of transcription The number of transcription factor-bound genes for classes C1-C5 is reported in the Online Methods. (e) 4C-seq analysis shows selective interactions between clustered transcription factor-bound enhancers and cell type-specific promoters. Note, for example, interactions between the ISL1 promoter and the C3-3 enhancer tested in transgenic zebrafish located >1 Mb away. The red triangle indicates the ISL1 promoter viewpoint, and pink lines highlight interactions between ISL1 and other sites. The 4C-seq track shows aligned sequences, and 4C-seq sites are significant interaction sites. (P < 1 × 10 −10 ). A green star marks region C3-3, which is shown in b to exhibit enhancer activity. (f) 4C-seq analysis of nine loci shows that C3 sites interact more often than expected by chance with nearby promoters in contrast with other accessible chromatin classes. Red diamonds depict the mean overlap of different accessible chromatin sites with viewpoint-interacting sites, whereas the gray box plot shows the overlap of randomized accessible chromatin sites (classes C1-C5) after 1,000 iterations at the same loci. (g) Transcription factor-bound C3 but not other transcription factor-bound sites establish frequent interactions with nearby promoters. Boxes show IQR, and whiskers extend to 1.5 times the IQR. npg A r t i c l e s factor binding sites that are important for cell type-specific gene activity.
Having shown that active enhancer clusters are pervasive at genes with islet-specific expression and, furthermore, that these clusters are critical for islet-specific gene activity, we examined the relationship between enhancer multiplicity and the formation of broad three-dimensional chromatin structures. We selected nine loci, eight of which contained active enhancer clusters near a gene with islet-enriched expression, and used human islet chromatin to perform circular chromosome conformation capture coupled with high-throughput sequencing (4C-seq) (Fig. 3e) 33 . Transcription factor-bound C3 sites from these clusters displayed frequent, strong interactions with the promoters of genes at the same loci with islet-enriched expression, including C3 sites located >1 Mb from their target promoter ( Fig. 3e-g ; additional loci are shown in Supplementary Fig. 10a-e) . In contrast, transcription factor-bound non-C3 sites at the same loci did not show greater interactions than expected by chance (P < 1 × 10 −3 for transcription factor-bound C3 sites versus randomized sites and P = 0.41 for transcription factor-bound non-C3 sites versus randomized sites) (Fig. 3f,g ). These observations suggest that islet enhancer clusters are three-dimensional structural units in which multiple transcription factor-bound active enhancers (rather than other transcription factor-bound sites) interact with target promoters. Collectively, the results indicate that human islet-specific gene transcription is largely driven by combinatorial transcription factor binding at clusters of enhancers that form three-dimensional chromatin structures.
Islet cis-regulatory sequence code
The identification of the genomic sites that underlie islet gene activity allowed us to explore the sequence code that is recognized by islet transcription factor networks to drive cell type-specific transcription. We identified 46 highly enriched sequence motifs in clustered enhancers, including recognition sequences for key β cell transcription factors (HNF1A, RFX, FOXA, NEUROD1, NKX6.1, PDX1, MAFA and MAFB), as well as previously unrecognized motifs (Fig. 4 and Supplementary Table 3) . We further identified combinations of these 46 motifs that were most enriched in islet enhancers relative to enhancers from 9 non-pancreatic cell types 34 ( Supplementary Fig. 11a-c) . Motifs for RFX 35 or the pioneer FOXA factors 36 were present in all of the most islet-enriched combinations (Supplementary Fig. 11b ), consistent with a major role for these factors in the activation of islet enhancers. To independently validate this analysis, we mapped all instances of the ten most enriched motif combinations to the mouse genome and found that they were also located near genes that show islet-enriched expression in mice (median expression of nearby genes in mouse islets versus non-islet tissues of 1.0 (IQR = 0.0-5.2) RPKM versus 0.6 (IQR = 0.0-3.7) RPKM; Wilcoxon P = 9.6 × 10 −31 ) ( Supplementary  Fig. 11d) . In silico analysis thus expanded the range of candidate combinatorial islet transcription factor interactions and provides a resource to discover new transcription factors and upstream signaling pathways that control β cell transcriptional programs.
Sequence variation in islet enhancers is associated with T2D
Genome-wide association studies (GWAS) have identified dozens of loci associated with T2D and glycemic traits 37, 38 , but the molecular mechanisms linking specific alleles to cellular functions remain poorly described. The catalog of islet cis-regulatory elements allowed us to explore to what extent genetic variants that contribute to T2D susceptibility and to variation in fasting glycemia in non-diabetic individuals act through islet regulatory mechanisms.
First, we examined loci with genome-wide significant association with T2D or fasting glycemia in European populations, considering all variants in high linkage disequilibrium (LD; 1000 Genomes Project CEU (Utah residents of Northern and Western European ancestry) r 2 > 0.8) with a lead SNP reported in the National Human Genome Research Institute (NHGRI) GWAS catalog 39 . These associated variants were enriched in C3 sites and occurred more prominently in clustered C3 rather than in orphan C3 sites (T2D: C3 P = 0.004; clustered C3 P = 0.012, orphan C3 P = 0.20; fasting glycemia: C3 P < 1 × 10 −5 ; clustered C3 P = 3 × 10 −5 , orphan C3 P = 0.12) (Fig. 5a) . There was no significant enrichment in variants associated with T2D or fasting glycemia for other accessible chromatin classes, and variants associated with other complex traits were not enriched at clustered islet C3 sites (all traits P > 0.05). Moreover, little enrichment was seen in the 200-bp sites immediately flanking C3 sites ( Fig. 5a ; T2D P = 0.44, fasting glycemia P = 0.043), suggesting that C3 enrichment is not driven solely by the genomic context of these sites. These findings indicate that a subset of loci with genome-wide association with T2D and fasting glycemia are likely to harbor functional cis-regulatory variants in islet active enhancers.
To further examine the contribution of islet cis-regulatory variation to T2D and fasting glycemia, we considered association results for the full set of ~2.5 million variants represented in the largest available genome-wide association meta-analyses for these traits rather than restricting analysis to signals reaching stringent genome-wide significance thresholds 37, 38 . For each islet accessible chromatin class, we identified the overlapping variants that exceeded a series of association significance thresholds and calculated fold enrichment values using a null distribution of permuted variant counts (Online Methods). Variants in C3 sites were collectively enriched for T2D and fasting glycemia genome-wide association values of P < 0.001 (T2D, C3 P = 2.1 × 10 −11 ; fasting glycemia, C3 P < 1 × 10 −16 ). This enrichment was predominantly a feature of C3 clusters rather than of orphan C3 sites (T2D: clustered C3 P = 5.1 × 10 −11 , orphan C3 P = 0.006; fasting glycemia: clustered C3 P < 1 × 10 −11 , orphan C3 P = 0.23) (Fig. 5b and  Supplementary Fig. 12 ). Fold enrichment patterns were unchanged when the genome-wide association data were aggressively pruned (r 2 > 0.2) to retain only the most associated signal in each LD cluster and remained significant for variants associated with T2D and fasting glycemia in clustered C3 sites (T2D: C3 P = 0.2, clustered C3 P = 0.031; fasting glycemia: C3 P = 3.6 × 10 −6 , clustered C3 P = 5.0 × 10 −5 ). Enrichment was also retained when established (genome-wide significant) npg T2D and fasting glycemia loci were removed ( Fig. 5b ; T2D: C3 P = 7.3 × 10 −5 , clustered C3 P = 1.1 × 10 −5 ; fasting glycemia: C3 P = 1.1 × 10 −5 , clustered C3 P = 4.1 × 10 −9 ), suggesting that the association of variants at C3 sites (and, in the T2D analysis, also of variants at C1 sites) extends to new loci that have yet to be confirmed to show genome-wide significant association with these traits. To further examine this point, we sought examples of variants overlapping islet accessible chromatin sites that mapped within such moderately associated loci. We found that rs72695654 disrupted a sequence motif and abolished binding of a β cell protein complex to a C3 site that is located in an enhancer cluster within the ACSL1 gene, which encodes a long-chain fatty acyl-CoA synthase that is highly expressed in islets (Supplementary Fig. 13a-c) . Long-chain fatty acyl-CoA synthesis has been implicated in β cell stimulus-secretion coupling, survival and lipotoxicity [40] [41] [42] . The rs72695654 variant was in high LD (1000 Genomes Project CEU r 2 = 0.94) with rs735949, which is strongly associated with T2D (P = 3.7 × 10 −6 ) and, independently, with Figure 5 Islet enhancers are enriched in loci associated with T2D and fasting glycemia.
(a) Loci associated with complex traits were tested for enrichment of overlap with classes of islet sites (C1-C5, clustered C3 and orphan C3) compared to matched background loci. Loci associated with T2D and fasting glycemia were enriched for islet active enhancer sites (C3) but not for directly flanking sites (C3 flanking) or for other islet classes. The enrichment of C3 sites for both T2D and fasting glycemia was stronger when considering clustered rather than orphan (non-clustered) enhancers. The most significant enrichments for other complex diseases were found for C1 sites with low-density lipoprotein (LDL) cholesterol (P = 0.022) and height (P = 0.026) and for C3 sites with Alzheimer's disease (P = 0.038). No significant enrichment of variants associated with other complex traits was seen in clustered C3 enhancers. HDL, high-density lipoprotein. The horizontal dashed line shows P value = 0.05 as a reference. (b) Enrichment of islet regulome sites in T2D 38 and fasting glycemia 37 genome-wide association data. We determined the number of variants overlapping sites from each islet accessible chromatin class that surpassed a series of association significance thresholds for T2D and fasting glycemia. We then calculated fold enrichment values at each threshold by comparison to the number of matched background variants significant at that threshold. C3 sites and clustered C3 sites were more enriched for T2D and fasting glycemia association at increasing P-value thresholds (left), even after removing known European (EUR) T2D and fasting glycemia loci (right). Patterns in C3 and clustered C3 sites were maintained when pruning variants to retain a single variant in each LD block (r 2 > 0.2). In all such analyses, clustered C3 sites displayed significant enrichment relative to the null distribution of permuted counts for T2D and fasting glycemia association P values of <0.001 (P values for these analyses are given in the text). 
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A r t i c l e s fasting glycemia levels in non-diabetic individuals in large genomewide association meta-analyses (P = 1.6 × 10 −5 ) 37, 38 ( Supplementary  Fig. 13a ). This finding suggests that cis-regulatory maps can be used to prioritize loci on the basis of which genetic evidence is strong, although not genome-wide significant, to guide hypothesis-driven experiments that define susceptibility variants. We next attempted to define functional enhancer variants in established genome-wide associated loci that might be causal in T2D susceptibility. We first catalogued all variants that resided within C3 sites and were in high LD with established genome-wide significant T2D and fasting glycemia association signals (Supplementary  Tables 4-6) 37, 38 . We confirmed that the TCF7L2 intronic SNP 43 rs7903146, previously shown to be located in an islet FAIREenriched site and to affect chromatin state and enhancer function 5 , mapped to a C3 site that is bound by NKX2.2, FOXA2 and MAFB, yet did not show active chromatin marks in an extensive panel of non-islet human cell types (Supplementary Fig. 14a,b) . Similar observations were made at multiple established T2D and fasting glycemia regions, including at SLC2A2, CDKN2A, C2CD4A, C2CD4B, SLC30A8, DGKB and PCSK1, where we identified associated variants that mapped to transcription factor-bound C3 sites, many of which disrupted islet-enriched sequence motifs (see Supplementary  Fig. 15a,b , which describes a public browser that facilitates the visualization of T2D and fasting glycemia genome-wide associated variants and the islet regulome, and Supplementary Fig. 16 ). For example, at the ZFAND3 T2D locus discovered in East Asians 44 , SNP rs58692659 formed part of an array of variants that was highly correlated with the reported lead SNP (rs9470794) (1000 Genomes Project CHB (Han Chinese in Beijing, China) and JPT (Japanese in Tokyo, Japan) r 2 = 0.96) and mapped to a C3 element bound by multiple islet transcription factors within an enhancer cluster (Fig. 6a) . This variant altered sequence-specific DNA binding of a key islet-enriched transcription factor, NEUROD1, and abolished enhancer activity in β cells (Fig. 6b,c) . We note that this SNP, along with many others in the region, is monomorphic in European samples (1000 Genomes Project CEU) and that there is no T2D association at ZFAND3 in Europeans (rs9470794 DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) P = 0.8) 44 , consistent with rs58692659 having a causal role at this locus. These results show how islet accessible chromatin maps can pinpoint functional cis-regulatory variants that are strong candidates for having a causal role in driving T2D association signals.
DISCUSSION
Our work provides reference cis-regulatory maps for ongoing efforts to dissect the transcriptional program of pancreatic β cells 45 and the molecular mechanisms of human T2D 10 . We show that islet-specific transcription factors establish widespread binding to accessible chromatin sites where they are apparently not engaged in regulation in cis of cell type-specific gene transcription. We further demonstrate that binding events that do drive the transcription of genes underlying islet cell identity reside in clusters of transcriptional enhancers. These clusters mirror previously reported clusters of accessible chromatin in human islets 5 , and, although they constitute groups of discrete enhancers, they share many features and may thus represent the same phenomenon as recently reported for large enhancers (superenhancers) 46, 47 . Our 4C-seq analysis allows us to speculate that enhancer multiplicity serves an architectural role by creating active chromatin structures in genomic domains that are transcriptionally silent in most non-islet cell types. These findings have therefore uncovered central cis-regulatory determinants of islet cell gene transcription.
Our systematic analysis implicates sequence variation at islet enhancer clusters in susceptibility to T2D and in variation in fasting glycemia levels. Recently, SNPs associated with common polygenic diseases were shown to be enriched in noncoding genomic elements defined by DNase I hypersensitivity, which marks accessible chromatin regions such as active promoters, insulators, repressors, and poised and active enhancers 48 , or by H3K4me3, which is enriched at promoters and, more weakly, at enhancers 49 . We have now defined for the first time, to our knowledge, functionally distinct transcription factor-bound genomic sites in human islets and have thereby disclosed that T2D susceptibility is specifically associated with allelic variation in pancreatic islet distant enhancers. Our results therefore link islet cis-regulatory networks to the mechanisms underlying T2D susceptibility and variation in glycemic traits. The availability of integrated cis-regulatory maps in pancreatic islets will facilitate hypothesis-driven experiments to establish the exact manner in which common and lower frequency genetic variants affect islet cells in human diabetes.
The islet regulome, including information on transcription factor occupancy, chromatin states, motifs, enhancer clusters and genomewide significant P values for association with T2D and fasting glycemia, can be accessed and visualized online (see URLs and Supplementary Fig. 15 for a description of this browser).
URLs. Islet Regulome Browser, http://www.isletregulome.org/.
METhODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METhODS
Human islets. Islets were isolated from donors without a history of glucose intolerance 52 , shipped in culture medium and then cultured for 3 d before analysis. β cells were purified by FACS as described 53 . Islet samples were selected from a set of 120 islet samples with ascertainment of minimal exocrine contamination, using dithizone staining and quantitative RT-PCR of lineagespecific markers (Supplementary Table 7) . High purity was also ascertained by strong H3K4me3 and H3K27ac enrichment at key β cell-specific genes, including INS, which shows no enrichment of histone marks in publically available human islet regulatory maps (Supplementary Fig. 2i ) 11, 12, 14 .
Ethics. Human pancreata were harvested from brain-dead organ donors after obtaining informed consent from family members. Islet isolation centers had permission to use islets for scientific research if they were insufficient for clinical islet transplantation, in accordance with national laws and institutional ethical requirements. Ethical approval for the project was given by the Clinical Research Ethics Committee of Hospital Clinic de Barcelona.
FAIRE and ChIP. Human islets processed for FAIRE and ChIP as described 5,54,55 using 1-1.5 µg of antibodies against H3K4me1 (ab-8895, Abcam), H3K4me3 (Upstate, 05-745), H3K27ac (ab4729, Abcam), CTCF (07-729, Millipore), H2A.Z (ab4174, Abcam; 09-862, Millipore), Pdx1 (AB2027, BCBC), FOXA2 (sc-6554, Santa Cruz Biotechnology), Nkx2.2 (HPA003468, Sigma), MafB (HPA005653, Sigma) and Nkx6.1 (HPA036774, Sigma). Expected cellspecific and subcellular patterns of formalin-fixed epitopes were ascertained by protein blotting on human islet extracts and dual immunofluorescence of human pancreas (Supplementary Fig. 1b,c) .
RNA sequencing. PolyA + RNA-seq data from three highly purified human islet samples and two FACS-purified human β cells have been described 29 . Non-pancreatic RNA-seq reads were from the Illumina human BodyMap2 project. We processed ~2.5 billion 50-bp paired-end reads from 14 human tissues or cell types (adipose, adrenal gland, breast, colon, heart, kidney, liver, lung, lymphatic node, muscle, ovary, prostate, thyroid gland and white blood cell) identically as for the islet data.
We defined (i) 1,000 islet-specific, non-redundant RefSeq transcripts with the highest median expression ratio in islets versus non-islet samples that were expressed in islets at >10 RPKM, (ii) 1,000 ubiquitously expressed transcripts with median islet versus non-islet expression ratios closest to 1 that had expression in islets of >10 RPKM and (iii)1,000 inactive transcripts with the lowest median RPKM expression in islets.
ChIP-seq analysis. Sequencing was performed on an Illumina HiSeq or Genome Analyzer IIx platform. Quality-filtered 36-to 51-bp single-end reads were aligned to the human genome (NCBI36/hC18) using Bowtie v0. 11.3 (ref. 56) , allowing only one mismatch and unique mapping. Clonal reads were removed. To calculate genome coverage densities, reads were extended in silico to a final length equal to the fragment size estimation based on MACS 57 and were averaged by the number of aligned reads in each ChIP-seq experiment. Sites enriched for transcription factor binding and H2A.Z were detected with MACS 57 using default parameters. Transcription factor peaks were called at P < 1 × 10 −10 and H2A.Z peaks were called at P < 1 × 10 −5 over a background model derived by sequencing input DNA (Supplementary Table 8 ). We only retained enrichment sites found in replicate experiments. To calculate FDR for replicated peaks, we balanced the number of input and sample reads with MACS and ascertained that >94% of peaks called at these thresholds showed FDR of <0.01. For FAIRE, we tuned the local background noise to λ local = max λ 5000 , λ 125000 and used a cutoff of P < 1 × 10 −3 , retaining only enrichment sites found in replicate experiments. We considered peaks to be overlapping if they shared a minimum of one base.
Accessible chromatin classes. Accessible chromatin was defined by merging all FAIRE-and H2A.Z-enriched sites that were found in at least two islet samples. These two established measures of accessible chromatin 5, 28 proved to be complementary, as FAIRE enrichment was weak in promoters yet readily identified central regions of enhancers and CTCF-bound sites, whereas H2A. Z enrichment was strongest in promoters and also marked enhancers and CTCF-bound sites (Fig. 2a and Supplementary Fig. 3a) . We generated 6-kb windows centered on each accessible chromatin site and computed the read coverage for each feature (H2A.Z, FAIRE, H3K4me3, H3K4me1, H3K27ac and CTCF binding) over 100-bp bins. Cluster3 (ref. 58 ) was used for k-median clustering with HI32, a single human islet sample for which data were available for all marks. For C1, two clusters that showed nearly identical histone modification enrichment patterns were artificially merged into a single class. Enrichment patterns at clusters (or accessible chromatin classes) were concordant in replicate samples (Supplementary Fig. 3b ).
Genome scan of enhancer clusters. To define enhancer clusters, we first created 1,000 iterations of randomized C3 sites in the mappable genome of individual chromosomes. We then calculated for each chromosome the 25th percentile of the between-site distances of randomized C3 sites ( Supplementary  Fig. 6a) . Next, we defined clusters of islet C3 sites as any group of ≥3 C3 sites in which all adjacent C3 sites were separated by less than the above-mentioned 25th-percentile distance for randomized sites in the same chromosome. The distribution of islet C3 clusters differed from those of clusters generated with randomized C3 sites (Supplementary Fig. 6b) .
We next created a score to measure the average transcription factor occupancy of islet enhancer (C3) clusters. For each cluster, we summed the number of binding sites for each transcription factor at C3 sites and divided this value by the number of C3 sites in the cluster. Clusters with higher average transcription factor occupancy were associated with genes with enriched transcription in islets and β cells (Supplementary Fig. 7a ). We defined highoccupancy clusters as those showing scores in the top two quartiles ( Fig. 2h and Supplementary Fig. 7a,b) .
For comparisons of RNA expression in islets and non-islet samples, we identified genes containing a transcription factor-bound enhancer cluster within 25 kb of their annotated TSS (Fig. 2h and Supplementary Fig. 7b) .
For sequence motif analysis, we examined all 19,624 C3 sites that formed clusters, including C3 sites not bound by the transcription factors we had profiled, as we had only profiled a subset of all islet factors. This set of clustered enhancers was also associated with islet-enriched transcription (Supplementary Fig. 6c) , and only 46% overlapped enhancer sites from nine non-pancreatic cells 34 .
We used the Genomic Regions Enrichment of Annotations Tool (GREAT) 59 with default parameters to study enriched functional categories among genes linked to transcription factor-bound enhancer clusters ( Supplementary  Fig. 7c ). We also used GREAT to determine which clusters were associated with a list of 65 genes with established importance for islet-specialized function and identity determined on the basis of a systematic literature search ( Supplementary Fig. 7d and Supplementary Table 2 ).
Transcription factor occupancy, chromatin state and islet-specific transcription. To compare transcription factor occupancy at different chromatin states in islet-specific and ubiquitous versus islet-inactive genes, we identified sites bound by >1 transcription factor in each chromatin class and calculated the density of such sites ±100 kb from the TSSs of the three groups of genes. This level of transcription factor occupancy was chosen to highlight that even high transcription factor occupancy at promoters is not selective for isletspecific gene expression, although conclusions remained unaltered using different numbers of transcription factors.
To directly examine genes bound by islet-specific transcription factors at different chromatin states, we compared quantile-normalized RNA expression in human islets, β cells and 14 non-pancreatic tissues. Data for non-pancreatic tissues were pooled in Figure 2g ,h and are given for individual tissues in Supplementary Figures 5b,d and 7b . We compared the mRNA expression of genes bound by transcription factors at C1 sites but lacking transcription factor-bound C3 chromatin within 25 kb of the TSS versus all other genes or genes containing transcription factor-bound C3 clusters within 25 kb of the TSS versus all other genes.
Enhancer function. Human sequences were cloned upstream of the hsp70 zebrafish core promoter 60 or the gata2 promoter 61 linked to a Venus reporter and used to inject >200 eggs from wild-type (AB*) and Tg(ins:mCherry)jh2 zebrafish in three independent experiments. Reporter expression patterns npg of loci in the background set associated with that trait containing a variant overlapping a site for each class (C1-C5) as well as clustered C3, orphan C3 and C3 flanking sites. We then permuted the set of loci by drawing from matching bins in the background set and recalculated the number of loci with a variant overlapping a site for that class. The significance of each overlap was calculated as the number of permuted sets with greater overlap than the observed set divided by the number of permutations. We ran 10,000 permutations except for fasting glycemia, for which we ran 100,000 permutations.
We then identified a comprehensive set of T2D and fasting glycemia index SNPs identified in any population. For T2D, we used all genome-wide significant lead SNPs reported in Morris et al. 38 and further identified lead SNPs for loci not genome-wide significant in that study but reported as such by previous studies. For fasting glycemia, we used all genome-wide significant lead SNPs reported in Scott et al. 37 for both fasting glycemia levels and fasting glycemia levels adjusted for body mass index loci (the former was retained when different lead SNPs at the same locus were reported).
For all lead SNPs, we identified variants in high LD (r 2 > 0.8) in 1000 Genomes Project phase I data for CEU samples (European loci), CHB and JPT samples (Asian loci) or YRI samples (African loci; Yoruba from Ibadan, Nigeria).
HapMap enrichment analysis. We obtained P values for all HapMap variants from DIAGRAM 38 and MAGIC 37 studies for T2D and fasting glycemia, respectively. Variants were pruned using LD from HapMap CEU samples as follows: first, all variants with r 2 > 0.2 with a lead SNP for a trait in Europeans were removed; second, remaining variants were sorted by P value, and variants were included if not having r 2 > 0.2 with a more significant variant. Both sets of variants (all HapMap and LD-pruned HapMap variants) were binned on the basis of CEU minor allele frequency and distance to the closest GENCODEv12 TSS. For analyses excluding known associated loci, variants in the 500-kb region surrounding each European lead SNP were removed.
A series of trait association P-value thresholds were set, and, at each threshold, the number of variants overlapping an islet chromatin class (C1-C5, clustered C3 and orphan C3) was counted. For each variant, a matching variant was then selected at random from the same bin, and the number of matched variants with a P value below the same threshold was counted. Fold enrichment was calculated for each threshold by dividing the observed counts by the matched counts averaged over 1,000 permutations.
To evaluate the significance of these enrichments, we focused on variants overlapping each chromatin class that attained P < 0.001 in T2D or fasting glycemia meta-analyses. We obtained counts of matched variants significant at the same trait P-value threshold across all permutations. As the matched variant counts for these replicates were normally distributed, we calculated a z score for the observed islet class counts using the mean and s.d. from the distribution of permuted counts. Reported P values were then obtained from z scores using a one-sided test.
